Friday, 21 June 2024


China-based Tianlong helps hospitals in Thailand for early detection of hepatitis

26 May 2023 | News

Expanding presence in Thailand and working closely with local partners

Tianlong, an innovative high-tech company specialising in molecular diagnostic products in China, has partnered with public hospitals in northern Thailand to build up detection measures for hepatitis C (HCV) and hepatitis B (HBV), and for the early diagnosis and treatment of the viruses.

Globally, more than 350 million people are living with viral hepatitis, and 9 in ten people living with hepatitis are unaware of their diagnosis. Tianlong's HCV&HBV detection solution can help reduce the transmission of the disease by enabling early diagnosis and proper treatment.

Since October 2022, Tianlong's HCV&HBV detection solution has been successfully installed in public hospitals in Thailand. The company has reached a 7-year agreement with local hospitals, and its solution will be seen in more local hospitals in the future.

Tianlong's HCV&HBV reagents, compatible with its nucleic acid extractor PANA9600S and PCR system Gentier 96, provide a rapid test with high sensitivity, which has received great praise from high-end users.

Tianlong's STIs solutions will also be applied in Thailand soon to help prevent and control sexually transmitted infections (STIs).

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account